Top 10 Drugs Losing Patent Exclusivity in US Market in 2021

Top 10 Drugs Losing Patent Exclusivity in US Market in 2021 are Lucentis (Genentech/Roche), Bystolic (AbbVie/Allergan), Vascepa (Amarin), Nothera (Lundbeck), Narcan (Emergent Biosolutions), Brovana (Sunovion), Sutent (Pfizer), Saphris (AbbVie/Allergan), Amitiza (Mallinckrodt), and Feraheme (Amag Pharma).

In 2021, there are many drugs in the US market that will lose patent exclusivity. Here we list top 10 of them.  These drugs may be grabbed market share by cheaper generics, which provides opportunities for generic drug manufacturers. The top 10 drugs are Lucentis (Genentech/Roche), Bystolic (AbbVie/Allergan), Vascepa (Amarin), Nothera (Lundbeck), Narcan (Emergent Biosolutions), Brovana (Sunovion), Sutent (Pfizer), Saphris (AbbVie/Allergan), Amitiza (Mallinckrodt), and Feraheme (Amag Pharma).

Top-10-Drugs-Losing-Patent-Exclusivity-in-US-Market-in-2021

Lucentis (Genentech/Roche)

  • Generic Name: Ranibizumab
  • CAS NO.: 347396-82-1
  • U.S. sales in 2020: $1.61 billion
  • Theraputic Area: age-related wet macular degeneration, macular edema after retinal vein occlusion, diabetic macular edema and diabetic retinopathy

Bystolic (AbbVie/Allergan),

  • Generic Name: Rebivolol
  • Molecular Formula: C22H25F2NO4
  • Molecular Weight: 405.43
  • CAS Registry Number: 118457-14-0
  • U.S. sales in 2020: undisclosed (2019 sales of $600 million)
  • Theraputic Area: Hypertension

Vascepa (Amarin)

  • Generic Name: Eicosapentaenoic acid ethyl ester
  • Molecular Formula:C22H34O2
  • Molecular Weight: 330.50
  • CAS Registry Number: 73310-10-8
  • U.S. sales in 2020: $598 million
  • Theraputic Area: hypertriglyceridemia and cardiovascular disease

Nothera (Lundbeck)

  • Generic Name:Droxidopa
  • Molecular Formula:C9H11NO5
  • Molecular Weight:213.19
  • CAS Registry Number:23651-95-8
  • U.S. sales in 2020: $416 million
  • Theraputic Area:Neurogenic orthostatic hypotension

Narcan (Emergent Biosolutions)

  • Generic Name:Naloxone
  • Molecular Formula:C19H21NO4
  • Molecular Weight: 327.37
  • CAS Registry Number: 465-65-6
  • U.S. sales in 2020: $311 millio
  • Theraputic Area:Opioid overdose

Brovana (Sunovion)

  • Generic Name:arformoterol
  • Molecular Formula:C19H24N2O4
  • Molecular Weight:344.41
  • CAS Registry Number:67346-49-0
  • U.S. sales in 2020: approximately $275 million
  • Theraputic Area:chronic obstructive pulmonary disease

Sutent (Pfizer)

  • Generic Name:sunitinib
  • Molecular Formula:C22H27FN4O2
  • Molecular Weight:398.47
  • CAS Registry Number:557795-19-4
  • U.S. sales in 2020: $2.23 million
  • Theraputic Area:gastrointestinal stromal tumors, advanced renal cell carcinoma and pancreatic neuroendocrine tumors

Saphris (AbbVie/Allergan)

  • Generic Name:asenapine
  • Molecular Formula:C17H16ClNO
  • Molecular Weight:285.77
  • CAS Registry Number:65576-45-6
  • U.S. sales in 2020: undisclosed (IQVIA estimates the market size to be 217 million US dollars)
  • Theraputic Area:schizophrenia and type I bipolar disorder

Amitiza (Mallinckrodt)

  • Generic Name:Asenapine
  • Molecular Formula:C17H16ClNO
  • Molecular Weight:285.77
  • CAS Registry Number:65576-45-6
  • U.S. sales in 2020: $180 million
  • Theraputic Area:constipation and irritable bowel syndrome

Feraheme (Amag Pharma)

  • Generic Name:ferumoxytol
  • CAS Registry Number:722492-56-0
  • U.S. sales in 2020: $150 million
  • Theraputic Area:Iron deficiency anemia
Like (2)
Previous 2021-09-01 23:01
Next 2021-09-06 13:48

Related Post